This program funded innovative research for preventing, detecting, diagnosing, and treating breast cancer. It sought to provide recent discoveries in basic science to women at risk for breast cancer and to those who need treatment. The program goal was to increase the number of new early-phase clinical breast cancer interventions and to help move promising drugs, biomarkers, and procedures into Phase III clinical trials.